AAAAAA

   
Results: 1-8 |
Results: 8

Authors: CLASSEN JB
Citation: Jb. Classen, CYCLOSPORINE-INDUCED AUTOIMMUNITY IN NEWBORNS PREVENTED BY EARLY IMMUNIZATION, Autoimmunity, 27(3), 1998, pp. 135-139

Authors: CLASSEN DC CLASSEN JB
Citation: Dc. Classen et Jb. Classen, THE TIMING OF PEDIATRIC IMMUNIZATION AND THE RISK OF INSULIN-DEPENDENT DIABETES-MELLITUS, Infectious diseases in clinical practice, 6(7), 1997, pp. 449-454

Authors: CLASSEN JB
Citation: Jb. Classen, TRIALS WITHOUT PLACEBO CONTROLS IN PRE-IDDM - IS THERE AN ADVANTAGE, Diabetes/metabolism reviews, 13(4), 1997, pp. 317-317

Authors: CLASSEN JB CLASSEN DC
Citation: Jb. Classen et Dc. Classen, INCIDENCE OF TYPE-1 DIABETES IN GERMANY IS NOT HIGHER THAN PREDICTED, Diabetes care, 20(11), 1997, pp. 1799-1800

Authors: CLASSEN JB
Citation: Jb. Classen, THE TIMING OF IMMUNIZATION AFFECTS THE DEVELOPMENT OF DIABETES IN RODENTS, Autoimmunity, 24(3), 1996, pp. 137-145

Authors: CLASSEN JB
Citation: Jb. Classen, THE DIABETES EPIDEMIC AND THE HEPATITIS-B VACCINES, New Zealand medical journal, 109(1030), 1996, pp. 366-366

Authors: CLASSEN JB CLASSEN DC
Citation: Jb. Classen et Dc. Classen, VACCINES MODULATE IDDM, Diabetologia, 39(4), 1996, pp. 500-501

Authors: CLASSEN JB SHEVACH EM
Citation: Jb. Classen et Em. Shevach, POST-THYMECTOMY ORGAN-SPECIFIC AUTOIMMUNITY - ENHANCEMENT BY CYCLOSPORINE-A AND INHIBITION BY IL-2, Autoimmunity, 15(1), 1993, pp. 55-59
Risultati: 1-8 |